The global landscape of biotechnology is undergoing a fundamental shift as the Pohang University of Science and Technology establishes a pioneering research hub designed to bridge the gap between laboratory discovery and commercial viability. This new entity, known as the Global Healthcare &
The persistent struggle to manage chronic inflammatory conditions has historically forced patients to choose between systemic immunosuppression and the logistical burden of frequent clinical infusions. While the introduction of biologics revolutionized the treatment of ulcerative colitis and
Japan’s life sciences landscape is undergoing a massive transformation as the nation leverages its deep scientific heritage to address the complexities of modern drug discovery and healthcare technology. This evolution is being catalyzed by the Japan Agency for Medical Research and Development,
As a veteran analyst of the biopharmaceutical landscape, Ivan Kairatov has spent years navigating the complex intersection of clinical innovation and market dynamics. With a background rooted in deep research and development, Kairatov has become a prominent voice advocating for a paradigm shift in
Achieving substantial weight reduction has historically required a combination of rigorous discipline and, more recently, the daunting prospect of weekly self-administered injections. This shift toward pharmacological intervention has been revolutionary, yet many individuals remain hesitant to
The European Commission’s recent authorization of AstraZeneca’s Imfinzi marks a significant shift in the therapeutic landscape for patients battling resectable gastric and gastro-esophageal junction cancers across the continent. This decision formalized the use of durvalumab as a perioperative
